Antiangiogenic Therapeutic Approaches in Multiple Myeloma

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|7|768-775

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.7, 2012-09, pp. : 768-775

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNA and Multiple Myeloma: from Laboratory Findings to Translational Therapeutic Approaches

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 5, 2014-05 ,pp. : 459-467

Bentham Science Publishers

Access to resources Recommend Favorite

Thalidomide as an Antiangiogenic Drug in the Treatment of Multiple Myeloma

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 2, 2004-04 ,pp. : 135-136

Bentham Science Publishers

Access to resources Recommend Favorite

The kinase NIK as a therapeutic target in multiple myeloma

By Gardam Sandra   Beyaert Rudi  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 207-218

Informa Healthcare

Access to resources Recommend Favorite

Current therapeutic uses of lenalidomide in multiple myeloma

By Hideshima Teru   Richardson Paul G   Anderson Kenneth C  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 171-179

Informa Healthcare

Access to resources Recommend Favorite

Targeting of Adhesion Molecules as a Therapeutic Strategy in Multiple Myeloma

By  

Current Cancer Drug Targets, Vol. 12, Iss. 7, 2012-09 ,pp. : 776-796

Bentham Science Publishers

Access to resources Recommend Favorite